Phase 4 Migraine Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are between 18 and 65 years old and were seen in the emergency department
- You came in with a headache that started recently (acute headache)
- Your pain level is at least 5 out of 10 on a pain scale
- You are fully awake, alert, and know who you are, where you are, and what time it is
- You are able to understand and agree to the consent process for joining the study
- You are able to describe any side effects you might feel and rate your pain using a number scale
Who may not be able to join:
- You have a known allergy to Rimegepant or Rizatriptan (the study medications)
- You are pregnant or breastfeeding
- Your vital signs (such as blood pressure or heart rate) are unstable
- You are unable to give your consent to participate
- Your headache is suspected to be caused by something other than migraine (for example, if you have a fever of 100.4°F or higher, neurological symptoms, or need emergency brain imaging) (confirm with trial site)
- You have heart disease, including chest pain (angina), a history of heart attack, or a condition where your heart arteries go into spasm (including Prinzmetal's angina)
- You have a history of stroke or mini-stroke (TIA)
- You have problems with blood flow to your legs or arms (peripheral vascular disease)
- You have reduced blood flow to your intestines (ischemic bowel disease)
- You have high blood pressure that is not well controlled
- You are currently using or have recently used certain other headache medications, including other triptans or ergotamine-type medications
- You have a specific type of migraine called hemiplegic or basilar migraine
- You are currently taking, or have stopped within the last 2 weeks, a type of antidepressant called an MAO-A inhibitor
- You are already taking Rimegepant regularly to prevent migraines
- You are experiencing severe nausea and vomiting
- Your headache is so severe that it needs immediate emergency treatment
- You have serious liver problems
- You are currently taking any of the following medications:
- Certain antidepressants, including MAO inhibitors (such as phenelzine, selegiline, or tranylcypromine), SSRIs (such as citalopram, escitalopram, or sertraline), duloxetine, fluoxetine, venlafaxine, or trazodone
- Certain other migraine medications, including sumatriptan, zolmitriptan, eletriptan, frovatriptan, almotriptan, dihydroergotamine, or ergotamine
- Certain muscle relaxants, including cyclobenzaprine
- Certain pain medications, including tramadol
- Certain antidepressants called tricyclics, including amitriptyline, nortriptyline, or protriptyline
- Amphetamine-based medications such as Adderall or Dexedrine
- Certain antifungal medications, including ketoconazole or itraconazole
- Certain antibiotics, including clarithromycin or erythromycin
- Certain antibiotics called rifamycins, such as rifampin or rifabutin
- Certain seizure medications, including carbamazepine or phenytoin
- Certain heart medications, including amiodarone, quinidine, ranolazine, or verapamil
- Cabergoline (a medication used for various hormonal conditions)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Sergey Motov, MD, Maimonides Medical Center
Phone: 718-283-6000
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change in Pain Score at 60 minutes
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.